Boaz Weinstein’s Pediatrix Medical MD Stock Holding History

Boaz Weinstein’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-53,700	Closed	-$625K	–	143
2020 Q1	$625K	Buy	+53,700	New	+$1.11M	0.03%	125

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Boaz Weinstein's MD Position: Q1 2025 in Review

Boaz Weinstein sold out of Pediatrix Medical (MD) in Q1 2025, closing a stake of 147,590 shares — an estimated $1.94M sold.

Boaz Weinstein first reported a position in MD in Q1 2020 and held it in 4 quarters. The position peaked at $2.34M in Q2 2024. 241 funds tracked by Wall St. Rank hold MD as of Q1 2025.

Boaz Weinstein reported no remaining Pediatrix Medical position as of Q1 2025 after selling out during the quarter.
Boaz Weinstein sold 147,590 Pediatrix Medical shares in Q1 2025, an estimated $1.94M.
Boaz Weinstein first reported a position in Pediatrix Medical in Q1 2020 and held it in 4 quarters.
Boaz Weinstein's Pediatrix Medical position peaked at $2.34M in Q2 2024.
241 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2025.

Based on Saba Capital Management's 13F filing for Q1 2025, filed 15 May 2025.